PL2350268T3 - Sposób wytwarzania wektorów adenowirusowych - Google Patents
Sposób wytwarzania wektorów adenowirusowychInfo
- Publication number
- PL2350268T3 PL2350268T3 PL09744140T PL09744140T PL2350268T3 PL 2350268 T3 PL2350268 T3 PL 2350268T3 PL 09744140 T PL09744140 T PL 09744140T PL 09744140 T PL09744140 T PL 09744140T PL 2350268 T3 PL2350268 T3 PL 2350268T3
- Authority
- PL
- Poland
- Prior art keywords
- production
- adenoviral vectors
- adenoviral
- vectors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10351—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Sustainable Development (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19812208P | 2008-11-03 | 2008-11-03 | |
EP08168181 | 2008-11-03 | ||
EP09744140.6A EP2350268B1 (en) | 2008-11-03 | 2009-10-29 | Method for the production of adenoviral vectors |
PCT/EP2009/064265 WO2010060719A1 (en) | 2008-11-03 | 2009-10-29 | Method for the production of adenoviral vectors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2350268T3 true PL2350268T3 (pl) | 2015-05-29 |
Family
ID=40344776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL09744140T PL2350268T3 (pl) | 2008-11-03 | 2009-10-29 | Sposób wytwarzania wektorów adenowirusowych |
Country Status (16)
Country | Link |
---|---|
US (1) | US10041049B2 (pl) |
EP (1) | EP2350268B1 (pl) |
JP (1) | JP5770633B2 (pl) |
KR (1) | KR101504392B1 (pl) |
CN (1) | CN102203242B (pl) |
AU (1) | AU2009319254B2 (pl) |
BR (1) | BRPI0921651A2 (pl) |
CA (1) | CA2742474C (pl) |
DK (1) | DK2350268T3 (pl) |
EA (1) | EA019928B1 (pl) |
ES (1) | ES2532015T3 (pl) |
HK (1) | HK1160664A1 (pl) |
MX (1) | MX2011004292A (pl) |
NZ (1) | NZ593235A (pl) |
PL (1) | PL2350268T3 (pl) |
WO (1) | WO2010060719A1 (pl) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2350268T3 (pl) | 2008-11-03 | 2015-05-29 | Crucell Holland Bv | Sposób wytwarzania wektorów adenowirusowych |
WO2011045378A1 (en) | 2009-10-15 | 2011-04-21 | Crucell Holland B.V. | Method for the purification of adenovirus particles |
PL2488635T3 (pl) * | 2009-10-15 | 2014-04-30 | Crucell Holland Bv | Proces do oczyszczania adenowirusa z hodowli o dużej gęstości komórek |
EP2536829B1 (en) * | 2010-02-15 | 2016-04-06 | Crucell Holland B.V. | Method for the production of Ad26 adenoviral vectors |
CN103118702A (zh) | 2010-09-20 | 2013-05-22 | 克鲁塞尔荷兰公司 | 活动性结核病的治疗性接种 |
AU2011310838B2 (en) | 2010-09-27 | 2015-11-05 | Crucell Holland B.V. | Heterologous prime boost vaccination regimen against malaria |
WO2012107436A1 (en) | 2011-02-10 | 2012-08-16 | Crucell Holland B.V. | Pneumatic alternating pressure membrane cell separation system |
WO2013074501A1 (en) | 2011-11-14 | 2013-05-23 | Crucell Holland B.V. | Heterologous prime-boost immunization using measles virus-based vaccines |
US8932607B2 (en) | 2012-03-12 | 2015-01-13 | Crucell Holland B.V. | Batches of recombinant adenovirus with altered terminal ends |
EA034284B1 (ru) | 2012-03-12 | 2020-01-24 | Янссен Вэксинс Энд Превеншн Б.В. | Частицы рекомбинантного трансгенсодержащего аденовируса с 5'-концевыми нуклеотидами ctatctat |
EP2827894B1 (en) | 2012-03-22 | 2017-05-17 | Janssen Vaccines & Prevention B.V. | Vaccine against rsv |
US9119813B2 (en) | 2012-03-22 | 2015-09-01 | Crucell Holland B.V. | Vaccine against RSV |
PT2988780T (pt) | 2013-04-25 | 2019-03-25 | Janssen Vaccines & Prevention Bv | Polipeptídeos f de pré-fusão do rsv solúveis estabilizados |
WO2014202570A1 (en) | 2013-06-17 | 2014-12-24 | Crucell Holland B.V. | Stabilized soluble pre-fusion rsv f polypeptides |
US10392603B2 (en) * | 2013-08-30 | 2019-08-27 | The Chemo-Sero-Therapeutic Research Institute | Method of viral purification |
EP3613841B1 (en) | 2014-03-25 | 2022-04-20 | Terumo BCT, Inc. | Passive replacement of media |
NZ730802A (en) | 2014-11-04 | 2021-12-24 | Janssen Vaccines & Prevention Bv | Therapeutic hpv16 vaccines |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
CA2991540A1 (en) | 2015-07-07 | 2017-01-12 | Janssen Vaccines & Prevention B.V. | Stabilized soluble pre-fusion respiratory syncytial sirus polypeptides |
BR112017027448A2 (pt) | 2015-07-07 | 2018-09-04 | Janssen Vaccines & Prevention Bv | vacina contra rsv |
US9663766B2 (en) | 2015-07-24 | 2017-05-30 | Bio-Rad Laboratories, Inc. | Methods for purifying adenovirus vectors |
JP6470872B2 (ja) | 2015-08-20 | 2019-02-13 | ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. | 治療用hpv18ワクチン |
US11155583B2 (en) | 2016-04-05 | 2021-10-26 | Janssen Vaccines & Prevention B.V. | Stabilized soluble pre-fusion RSV F proteins |
MA43762A (fr) | 2016-04-05 | 2021-04-21 | Janssen Vaccines & Prevention Bv | Vaccin contre le rsv |
AU2017249402A1 (en) * | 2016-04-12 | 2018-10-04 | Artemis Biosystems, Inc. | Perfusion filtration systems |
BR112018072372A2 (pt) | 2016-05-02 | 2019-02-19 | Janssen Vaccines & Prevention B.V. | combinações de vacina terapêutica contra o hpv |
WO2017205667A1 (en) | 2016-05-25 | 2017-11-30 | Terumo Bct, Inc. | Cell expansion |
CA3025441A1 (en) | 2016-05-30 | 2017-12-07 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion rsv f proteins |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
EP3484506A1 (en) | 2016-07-14 | 2019-05-22 | Janssen Vaccines & Prevention B.V. | Hpv vaccines |
CN117247899A (zh) | 2017-03-31 | 2023-12-19 | 泰尔茂比司特公司 | 细胞扩增 |
EP3624844A1 (en) | 2017-05-17 | 2020-03-25 | Janssen Vaccines & Prevention B.V. | Methods and compositions for inducing protective immunity against rsv infection |
MX2020002876A (es) | 2017-09-15 | 2020-07-22 | Janssen Vaccines & Prevention Bv | Metodo para la induccion segura de inmunidad contra el vsr. |
SG11202003290RA (en) | 2017-10-31 | 2020-05-28 | Janssen Vaccines & Prevention Bv | Adenovirus and uses thereof |
JP7438943B2 (ja) | 2017-10-31 | 2024-02-27 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | アデノウイルス及びその用途 |
KR20200077559A (ko) | 2017-10-31 | 2020-06-30 | 얀센 백신스 앤드 프리벤션 비.브이. | 아데노바이러스 및 이의 용도 |
SG11202003398SA (en) | 2017-10-31 | 2020-05-28 | Janssen Vaccines & Prevention Bv | Adenovirus vectors and uses thereof |
EP3724229A1 (en) * | 2017-12-11 | 2020-10-21 | Amgen Inc. | Continuous manufacturing process for bispecific antibody products |
CN110317832B (zh) * | 2018-03-28 | 2022-07-05 | 西比曼生物科技(香港)有限公司 | Gmp级规模化制备重组慢病毒载体的纯化制剂的方法 |
CN110317791A (zh) | 2018-03-29 | 2019-10-11 | 西比曼生物科技(香港)有限公司 | Gmp级无血清悬浮细胞大规模生产慢病毒的方法 |
US20210047626A1 (en) | 2018-04-24 | 2021-02-18 | Merck Sharp & Dohme Corp. | Scalable chromatography process for purification of human cytomegalovirus |
CA3144960A1 (en) * | 2019-07-01 | 2021-01-07 | Ology Bioservices, Inc. | Method for cultivation of adherent cells in a multiparallel bioreactor |
TW202204380A (zh) | 2020-01-31 | 2022-02-01 | 美商詹森藥物公司 | 用於預防及治療冠狀病毒感染之組合物及方法-sars-cov-2疫苗 |
GB202013940D0 (en) | 2020-09-04 | 2020-10-21 | Synpromics Ltd | Regulatory nucleic acid sequences |
AU2021358957A1 (en) | 2020-10-07 | 2023-06-08 | Asklepios Biopharmaceutical, Inc. | Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 |
MX2023011629A (es) | 2021-04-01 | 2023-10-13 | Janssen Vaccines & Prevention Bv | Proteinas piv3 f prefusion estabilizadas. |
WO2023020939A1 (en) | 2021-08-17 | 2023-02-23 | Janssen Pharmaceuticals, Inc. | Sars-cov-2 vaccines |
WO2023111725A1 (en) | 2021-12-14 | 2023-06-22 | Janssen Pharmaceuticals, Inc. | Sars-cov-2 vaccines |
WO2023110618A1 (en) | 2021-12-16 | 2023-06-22 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion hmpv fusion proteins |
WO2024061753A1 (en) | 2022-09-23 | 2024-03-28 | Janssen Vaccines & Prevention B.V. | Stabilized trimeric class i fusion proteins |
WO2024061757A1 (en) | 2022-09-23 | 2024-03-28 | Janssen Vaccines & Prevention B.V. | Pre-fusion human piv1 f proteins |
WO2024074584A1 (en) | 2022-10-06 | 2024-04-11 | Janssen Vaccines & Prevention B.V. | Stabilized pre-fusion piv3 f proteins |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04241381A (ja) * | 1991-01-16 | 1992-08-28 | Brother Ind Ltd | 電子学習機 |
FR2705686B1 (fr) * | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
US5851806A (en) * | 1994-06-10 | 1998-12-22 | Genvec, Inc. | Complementary adenoviral systems and cell lines |
EP0784690B1 (en) * | 1994-06-10 | 2006-08-16 | Genvec, Inc. | Complementary adenoviral vector systems and cell lines |
US5846782A (en) * | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
US5559099A (en) * | 1994-09-08 | 1996-09-24 | Genvec, Inc. | Penton base protein and methods of using same |
US5965541A (en) * | 1995-11-28 | 1999-10-12 | Genvec, Inc. | Vectors and methods for gene transfer to cells |
US5770442A (en) | 1995-02-21 | 1998-06-23 | Cornell Research Foundation, Inc. | Chimeric adenoviral fiber protein and methods of using same |
US5837520A (en) * | 1995-03-07 | 1998-11-17 | Canji, Inc. | Method of purification of viral vectors |
ES2333425T5 (es) * | 1995-06-15 | 2012-08-28 | Crucell Holland B.V. | Sistemas de empaquetado para adenovirus recombinante humano destinados a terapia génica |
EP0847442A1 (en) | 1995-08-30 | 1998-06-17 | Genzyme Corporation | Chromatographic purification of adenovirus and aav |
US5837511A (en) * | 1995-10-02 | 1998-11-17 | Cornell Research Foundation, Inc. | Non-group C adenoviral vectors |
CA2177085C (en) * | 1996-04-26 | 2007-08-14 | National Research Council Of Canada | Adenovirus e1-complementing cell lines |
JP2000514290A (ja) * | 1996-07-01 | 2000-10-31 | ローヌ―プーラン・ロレ・エス・アー | 組換えアデノウイルスの製造方法 |
FR2751343B1 (fr) | 1996-07-16 | 1998-12-18 | Transgene Sa | Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament |
BR9713368A (pt) | 1996-11-20 | 2001-09-18 | Introgen Therapeutics Inc | Processo melhorado para a produção e a purificação de vetores adenovirais |
US7732129B1 (en) * | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
US6261823B1 (en) | 1996-12-13 | 2001-07-17 | Schering Corporation | Methods for purifying viruses |
JP2000509614A (ja) | 1997-03-04 | 2000-08-02 | バクスター インターナショナル インコーポレイテッド | アデノウイルスe1−相補性細胞系 |
US6020191A (en) * | 1997-04-14 | 2000-02-01 | Genzyme Corporation | Adenoviral vectors capable of facilitating increased persistence of transgene expression |
US6210683B1 (en) | 1997-09-05 | 2001-04-03 | Merck & Co., Inc. | Stabilizers containing recombinant human serum albumin for live virus vaccines |
TWI232107B (en) | 1998-02-17 | 2005-05-11 | Schering Corp | Compositions comprising viruses and methods for concentrating virus preparations |
US5981225A (en) * | 1998-04-16 | 1999-11-09 | Baylor College Of Medicine | Gene transfer vector, recombinant adenovirus particles containing the same, method for producing the same and method of use of the same |
WO1999054441A1 (en) * | 1998-04-22 | 1999-10-28 | Genvec, Inc. | Efficient purification of adenovirus |
US6113913A (en) * | 1998-06-26 | 2000-09-05 | Genvec, Inc. | Recombinant adenovirus |
US20030017138A1 (en) | 1998-07-08 | 2003-01-23 | Menzo Havenga | Chimeric adenoviruses |
US20040043489A1 (en) * | 1998-07-08 | 2004-03-04 | Menzo Havenga | Gene delivery vectors provided with a tissue tropism for dendritic cells and methods of use |
EP1977764A1 (en) | 1998-11-16 | 2008-10-08 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
JP2003523169A (ja) * | 1998-12-31 | 2003-08-05 | アバンテイス・フアルマ・エス・アー | ウイルス粒子の分離法 |
ATE332364T1 (de) | 1999-02-22 | 2006-07-15 | Transgene Sa | Verfahren zur gewinnung von purifizierter virenzuammensetzung |
PT1550722E (pt) | 1999-05-17 | 2007-09-25 | Crucell Holland Bv | ''adenovírus humano recombinante do serótipo 35'' |
US6492169B1 (en) * | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
US6913922B1 (en) * | 1999-05-18 | 2005-07-05 | Crucell Holland B.V. | Serotype of adenovirus and uses thereof |
US20050232900A1 (en) * | 1999-05-18 | 2005-10-20 | Crucell Holland B.V. | Serotype of adenovirus and uses thereof |
DE19955558C2 (de) | 1999-11-18 | 2003-03-20 | Stefan Kochanek | Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren |
US6544424B1 (en) * | 1999-12-03 | 2003-04-08 | Refined Technology Company | Fluid filtration system |
AU4346101A (en) | 2000-03-07 | 2001-09-17 | Merck & Co., Inc. | Adenovirus formulations |
US7235233B2 (en) * | 2000-09-26 | 2007-06-26 | Crucell Holland B.V. | Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts |
US20020064860A1 (en) | 2000-11-29 | 2002-05-30 | Schering Corporation | Method for purifying adenoviruses |
WO2003049764A1 (en) | 2001-12-12 | 2003-06-19 | Fh Faulding & Co Limited | Composition for viral preservation |
JP4488290B2 (ja) * | 2002-01-24 | 2010-06-23 | ザ・スクリップス・リサーチ・インスティテュート | 効率的ターゲティングのためのファイバーシャフト変異 |
US20030180936A1 (en) | 2002-03-15 | 2003-09-25 | Memarzadeh Bahram Eric | Method for the purification, production and formulation of oncolytic adenoviruses |
EP1497438B1 (en) * | 2002-04-25 | 2009-10-28 | Crucell Holland B.V. | Means and methods for the production of adenovirus vectors |
CA2478508C (en) * | 2002-04-25 | 2013-07-02 | Crucell Holland B.V. | Stable adenoviral vectors and methods for propagation thereof |
ES2285120T3 (es) | 2002-05-14 | 2007-11-16 | MERCK & CO., INC. | Procedimientos de purificacion de adenovirus. |
EP1553983A2 (en) * | 2002-10-23 | 2005-07-20 | Crucell Holland B.V. | New settings for recombinant adenoviral-based vaccines |
US20080153083A1 (en) * | 2003-10-23 | 2008-06-26 | Crucell Holland B.V. | Settings for recombinant adenoviral-based vaccines |
EP2258850B1 (en) * | 2002-12-17 | 2013-07-17 | Crucell Holland B.V. | Recominant viral-based malaria vaccins |
WO2004099422A2 (en) * | 2003-03-28 | 2004-11-18 | The Scripps Research Institute | Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
BRPI0414670A (pt) * | 2003-10-02 | 2006-11-21 | Crucell Holland Bv | método para preparar uma célula, célula, métodos para fornecer uma célula e para gerar uma batelada de adenovìrus recombinante, molécula recombinante, conjunto de pelo menos duas moléculas de ácido nucleico, e, sistema de empacotamento |
EP1718738A2 (en) * | 2004-02-23 | 2006-11-08 | Crucell Holland B.V. | Virus purification methods |
US8206981B2 (en) * | 2004-03-05 | 2012-06-26 | Dsm Ip Assets B.V. | Process for cell culturing by continuous perfusion and alternating tangential flow |
CN102492607B (zh) | 2004-06-04 | 2014-12-10 | 通用电气医疗集团生物科学公司 | 一次性生物反应器系统及方法 |
US7741099B2 (en) * | 2004-10-13 | 2010-06-22 | Beth Israel Deaconess Medical Center Inc. | Adenoviral vectors and uses thereof |
AU2005293572B2 (en) * | 2004-10-14 | 2011-08-04 | Crucell Holland B.V. | Malaria prime/boost vaccines |
BRPI0518933A2 (pt) | 2004-11-16 | 2008-12-16 | Crucell Holland B V E Aeras Gl | adenovÍrus recombinante defeituoso de replicaÇço, vetor de polinucleotÍdeo recombinante, vacina multivalente da tuberculose, e, uso do antÍgeno tb10.4 de mycobacterium |
EP1851343A2 (en) | 2005-02-11 | 2007-11-07 | Merck and Co., Inc. | Adenovirus serotype 26 vectors, nucleic acid and viruses produced thereby |
CN101155915B (zh) * | 2005-04-11 | 2013-12-04 | 克鲁塞尔荷兰公司 | 利用超滤进行病毒纯化 |
CA2609276A1 (en) * | 2005-05-23 | 2006-11-30 | De-Chu C. Tang | Rapid production of adenovirus-free recombinant adenovirus vectors |
EP1917317A2 (en) | 2005-07-22 | 2008-05-07 | Pergo (Europe) AB | Flooring system including a dry glue |
ES2620789T3 (es) * | 2005-08-15 | 2017-06-29 | Altimmune Inc. | Inmunización de aves por administración de vacunas con vectores no replicantes |
US20100143302A1 (en) * | 2006-03-16 | 2010-06-10 | Crucell Holland B.V. | Recombinant Adenoviruses Based on Serotype 26 and 48, and Use Thereof |
US20090110695A1 (en) | 2006-03-27 | 2009-04-30 | Menzo Jans Emko Havenga | Compositions Comprising a Recombinant Adenovirus and an Adjuvant |
MX2009000650A (es) * | 2006-07-18 | 2009-07-02 | Secretary Of The Army The Unit | Vacunas para malaria. |
EA021391B1 (ru) * | 2007-03-02 | 2015-06-30 | Глаксосмитклайн Байолоджикалс С.А. | Способ индукции иммунного ответа, вакцинная композиция, ее применение и набор |
US9109193B2 (en) | 2007-07-30 | 2015-08-18 | Ge Healthcare Bio-Sciences Corp. | Continuous perfusion bioreactor system |
WO2009064265A1 (en) | 2007-11-14 | 2009-05-22 | Chun-Chieh Chang | Method and devices for producing air sensitive electrode materials for lithium ion battery applications |
WO2009117134A2 (en) * | 2008-03-21 | 2009-09-24 | National Institutes Of Health | Aerosolized genetic vaccines and methods of use |
PL2350268T3 (pl) | 2008-11-03 | 2015-05-29 | Crucell Holland Bv | Sposób wytwarzania wektorów adenowirusowych |
ES2484093T3 (es) | 2009-07-16 | 2014-08-11 | Crucell Holland B.V. | Producción de poliovirus con títulos elevados para producción de vacunas |
PL2488635T3 (pl) | 2009-10-15 | 2014-04-30 | Crucell Holland Bv | Proces do oczyszczania adenowirusa z hodowli o dużej gęstości komórek |
EP2536829B1 (en) | 2010-02-15 | 2016-04-06 | Crucell Holland B.V. | Method for the production of Ad26 adenoviral vectors |
US20120315696A1 (en) | 2010-02-15 | 2012-12-13 | Alfred Luitjens | METHOD FOR THE PRODUCTION OF Ad26 ADENOVIRAL VECTORS |
-
2009
- 2009-10-29 PL PL09744140T patent/PL2350268T3/pl unknown
- 2009-10-29 US US13/126,978 patent/US10041049B2/en active Active
- 2009-10-29 BR BRPI0921651-0A patent/BRPI0921651A2/pt not_active Application Discontinuation
- 2009-10-29 JP JP2011533718A patent/JP5770633B2/ja active Active
- 2009-10-29 NZ NZ593235A patent/NZ593235A/xx not_active IP Right Cessation
- 2009-10-29 ES ES09744140.6T patent/ES2532015T3/es active Active
- 2009-10-29 AU AU2009319254A patent/AU2009319254B2/en not_active Ceased
- 2009-10-29 WO PCT/EP2009/064265 patent/WO2010060719A1/en active Application Filing
- 2009-10-29 DK DK09744140.6T patent/DK2350268T3/en active
- 2009-10-29 EA EA201170638A patent/EA019928B1/ru not_active IP Right Cessation
- 2009-10-29 EP EP09744140.6A patent/EP2350268B1/en active Active
- 2009-10-29 CA CA2742474A patent/CA2742474C/en active Active
- 2009-10-29 KR KR1020117010793A patent/KR101504392B1/ko active IP Right Grant
- 2009-10-29 CN CN2009801438951A patent/CN102203242B/zh active Active
- 2009-10-29 MX MX2011004292A patent/MX2011004292A/es active IP Right Grant
-
2012
- 2012-01-31 HK HK12100868.5A patent/HK1160664A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2010060719A1 (en) | 2010-06-03 |
JP5770633B2 (ja) | 2015-08-26 |
CA2742474C (en) | 2016-05-31 |
KR20110093793A (ko) | 2011-08-18 |
JP2012507270A (ja) | 2012-03-29 |
EA019928B1 (ru) | 2014-07-30 |
US20110207202A1 (en) | 2011-08-25 |
AU2009319254A1 (en) | 2010-06-03 |
AU2009319254B2 (en) | 2015-04-30 |
ES2532015T3 (es) | 2015-03-23 |
CA2742474A1 (en) | 2010-06-03 |
CN102203242A (zh) | 2011-09-28 |
BRPI0921651A2 (pt) | 2015-08-18 |
MX2011004292A (es) | 2011-05-31 |
US10041049B2 (en) | 2018-08-07 |
HK1160664A1 (en) | 2012-08-10 |
EA201170638A1 (ru) | 2011-12-30 |
NZ593235A (en) | 2013-02-22 |
EP2350268B1 (en) | 2014-12-24 |
DK2350268T3 (en) | 2015-03-23 |
EP2350268A1 (en) | 2011-08-03 |
CN102203242B (zh) | 2013-06-12 |
KR101504392B1 (ko) | 2015-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1160664A1 (en) | Method for the production of adenoviral vectors | |
PL2536829T3 (pl) | Sposób wytwarzania wektorów adenowirusowych Ad26 | |
TWI560176B (en) | Batch system for the production of olefins | |
ZA201103860B (en) | System for the production of hydrogen | |
PL2349957T3 (pl) | Proces wytwarzania hydrofluoroolefin | |
ZA200907811B (en) | Process for the manufacture of p4o6 | |
HUE037762T2 (hu) | Eljárás biotermékek elõállítására | |
GB0702695D0 (en) | Production of vectors | |
EP2135946A4 (en) | METHOD FOR MANUFACTURING A POLYPEPTIDE | |
PL2151428T3 (pl) | Nowy sposób syntezy agomelatyny | |
GB0820631D0 (en) | Vectors | |
IL208792A0 (en) | Process for the preparation of amides | |
GB0801209D0 (en) | Process | |
IL216942A0 (en) | Process for the manufacture of alkenones | |
GB0801580D0 (en) | Process | |
PL2250211T3 (pl) | Sposoby wytwarzania polioli | |
GB0800875D0 (en) | Process | |
EP2344468A4 (en) | PROCESS FOR PREPARING RAMELTÉON | |
GB0812400D0 (en) | Process | |
PT2151429E (pt) | Novo processo de síntese da agomelatina | |
EG26332A (en) | Process for the preparation of benzonoprons | |
GB0802497D0 (en) | Build process | |
GB0707723D0 (en) | Method for the production of bio-ethanol | |
IL211382A0 (en) | Process for the preparation of ethanedinitrile | |
IL200230A0 (en) | Method for the production of ??-ketonitriles |